Shi 2018.

Study characteristics
Methods	RCT; parallel design Review comparison group: hemiarthroplasty versus internal fixation with PFLP
Participants	Total number of randomised participants: 80 Inclusion criteria: intertrochanteric fractures; signed informed consent for enrolment, operation and anaesthesia Exclusion criteria: severe cardiopulmonary insufficiency; severe liver and kidney function deficiency; coagulation disorder; spinal deformity; malignant tumours; fractures in other parts of lower limbs; mental illness; used analgesia device after operation; refused enrolment Setting: single centre, hospital, China Baseline characteristics Intervention group 1 (observation) Age, average (SD) (range): 73.5 (1.3) (60 to 85) years Gender, M/F: 20/20 Evans‐Jensen classification, I/II/III/IV, n: 3/3/16/18 HHS, average (SD): 35.6 (± 2.1) points Intervention group 2 (PFLP) Age, mean (SD): 73.6 (± 1.3 ) years Gender, M/F: 21/19 Evans‐Jensen classification, I/II/III/IV, n: 3/3/16/18 HHS, average (SD): 35.5 (± 2.1) points Note: study authors do not report baseline characteristics for: smoking history; medication; BMI; comorbidities; mobility assessment; place of residence; cognitive status/dementia; preoperative waiting time; and no baseline characteristics for group 2 (except preoperative HHS)
Interventions	General details: all participants were treated with spinal‐epidural anaesthesia in a lateral position; followed up at 12 months Intervention group 1 Cemented hemiarthroplasty (manufacturer not  reported) Number randomised = 40 Intervention group 2 Proximal femoral locking plate (manufacturer not  reported); static femoral head fixation with multiple screws Number randomised = 40 Note: study authors do not report: the number of clinicians or their skills and experience; any detail on the pre‐/postoperative care
Outcomes	Outcomes measured/reported by study authors: operation time; intraoperative blood loss; postoperative drainage time; walking speed; 5‐times sit‐to‐stand test time; HHS; pain; hospital stay; time walking on crutches and walking without; complications; HRQoL (available at 12 months) Outcomes relevant to the review: HRQoL (in SF‐12, reported at 12 months, physical and psychological scores are available)  Note: we did not include data for HRQoL in analysis; losses were not reported and we expected these data were incomplete because of death
Notes	Funding/sponsor/declarations of interest: study authors report no funding was received with no conflicts of interest Study dates: May 2014 to December 2016 Note: we did not conduct risk of bias assessment because we were unable to include data for any outcomes in the review.